[Federal Register Volume 76, Number 32 (Wednesday, February 16, 2011)]
[Notices]
[Page 9018]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-3525]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control

    Special Emphasis Panel (SEP): Annual Estimates of Influenza Vaccine 
Effectiveness for Preventing Laboratory-Confirmed Influenza in the 
United States, Funding Opportunity Announcement (FOA), IP11-003, 
Initial Review
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date: 8 a.m.-5 p.m., April 7, 2011 (Closed).
    Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, 
Atlanta, Georgia 30337, Telephone: (770) 997-1100.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Annual Estimates of Influenza Vaccine Effectiveness for Preventing 
Laboratory-Confirmed Influenza in the United States, FOA IP11-003.''
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., 
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498-2293. The 
Director, Management Analysis and Services Office, has been delegated 
the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: February 4, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-3525 Filed 2-15-11; 8:45 am]
BILLING CODE 4163-18-P